LivaNova (LIVN) Non-Current Assets (2015 - 2026)
LivaNova (LIVN) posted Non-Current Assets of $1.5 billion for Q1 2026, little changed sequentially from $1.5 billion in Q4 2025, and up 8.25% YoY from $1.4 billion in Q1 2025.
LivaNova (LIVN) Non-Current Assets (2015 - 2026) Analysis & Trends
LivaNova has reported Non-Current Assets for 12 years, with the latest figure at $1.5 billion in Q1 2026.
- Quarterly Non-Current Assets rose 8.25% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 billion (up 47.54% YoY) and the FY2025 annual result came in at $1.5 billion, up 9.08% from the prior year.
- Non-Current Assets held at $1.5 billion in Q1 2026 per LIVN's latest filing, from $1.5 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.6 billion in Q1 2022 and troughed at -$191.6 million in Q2 2024.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 113.69% in 2024, then soared 851.89% in 2025.
- Over 5 years, Non-Current Assets stood at $1.4 billion in 2022, then increased by 2.33% to $1.4 billion in 2023, then decreased by 4.32% to $1.4 billion in 2024, then grew by 9.08% to $1.5 billion in 2025, then slipped by 0.15% to $1.5 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.5 billion, $1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 8.29 Bn |
| 10 | LivaNova | 4.33 Bn | 3.81 Bn | 273.67 Mn | 1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | -191.59 Mn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.56 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.56 Bn |